Ibrahim Musa Yola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ibrahim Musa Yola has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Ramachandran S. Vasan
Boston University and NHLBI’s Framingham Study
5 shared publications - Vanessa Xanthakis
Boston University Chobanian and Avedisian School of Medicine
5 shared publications Abdulrazaq G. Habib
Department of Medicine Infectious and Tropical Diseases Unit Aminu Kano Teaching Hospital Bayero University Kano Kano Nigeria
2 shared publications- Emad Kandil
Department of Surgery Tulane University School of Medicine New Orleans Louisiana USA
2 shared publications Hamza Muhammad
Department of Medicine Infectious and Tropical Diseases Unit Aminu Kano Teaching Hospital Bayero University Kano Kano Nigeria
2 shared publicationsRebecca J. Song
Department of Epidemiology Boston University School of Public Health Boston MA
2 shared publications
Latest Publications
- Open Access
- 15 March 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (6) , e024202
Prevalence, Predictors, Progression, and Prognosis of Hypertension Subtypes in the Framingham Heart Study
Background: The epidemiology of hypertension subtypes has not been well characterized in the recent era. Methods and Results: We delineated the prevalence, predictors, progression, and prognostic significance of hypertension subtypes in 8198 Framingham Heart Study participants (mean age, 46.5 years; 54% women). The prevalence of hypertension subtypes was as follows: nonhypertensive (systolic blood pressure [SBP] <140 mm Hg and diastolic blood pressure [DBP] <90 mm Hg), 79%; isolated systolic hypertension (ISH; SBP ≥140 mm Hg and DBP <90 mm Hg), 8%; isolated diastolic hypertension (SBP <140 mm Hg and DBP ≥90 mm Hg), 4%; and systolic‐diastolic hypertension (SDH; SBP ≥140 mm Hg and DBP ≥90 mm Hg), 9%. The prevalence of ISH and SDH increased with age. Analysis of a subsample of nonhypertensive participants demonstrated that increasing age, female sex, higher heart rate, left ventricular mass, and greater left ventricular concentricity were predictors of incident ISH and SDH. Higher baseline DBP was associated with the risk of developing isolated diastolic hypertension and SDH, whereas higher SBP was associated with all 3 hypertension subtypes. On follow‐up (median, 5.5 years), isolated diastolic hypertension often reverted to nonhypertensive BP (in 42% of participants) and ISH progressed to SDH (in 26% of participants), whereas SDH frequently transitioned to ISH (in 20% of participants). During follow‐up (median, 14.6 years), 889 participants developed cardiovascular disease. Compared with the nonhypertensive group (referent), ISH (adjusted hazard ratio [HR], 1.57; 95% CI, 1.30–1.90) and SDH (HR, 1.66; 95% CI, 1.36–2.01) were associated with increased cardiovascular disease risk, whereas isolated diastolic hypertension was not (HR, 1.03; 95% CI, 0.68–1.57). Conclusions: Hypertension subtypes vary in prevalence with age, are dynamic during short‐term follow‐up, and exhibit distinctive prognoses, underscoring the importance of blood pressure subphenotyping.
- 15 March 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (6) , e024202
Open AccessPrevalence, Predictors, Progression, and Prognosis of Hypertension Subtypes in the Framingham Heart Study
Background: The epidemiology of hypertension subtypes has not been well characterized in the recent era. Methods and Results: We delineated the prevalence, predictors, progression, and prognostic significance of hypertension subtypes in 8198 Framingham Heart Study participants (mean age, 46.5 years; 54% women). The prevalence of hypertension subtypes was as follows: nonhypertensive (systolic blood pressure [SBP] <140 mm Hg and diastolic blood pressure [DBP] <90 mm Hg), 79%; isolated systolic hypertension (ISH; SBP ≥140 mm Hg and DBP <90 mm Hg), 8%; isolated diastolic hypertension (SBP <140 mm Hg and DBP ≥90 mm Hg), 4%; and systolic‐diastolic hypertension (SDH; SBP ≥140 mm Hg and DBP ≥90 mm Hg), 9%. The prevalence of ISH and SDH increased with age. Analysis of a subsample of nonhypertensive participants demonstrated that increasing age, female sex, higher heart rate, left ventricular mass, and greater left ventricular concentricity were predictors of incident ISH and SDH. Higher baseline DBP was associated with the risk of developing isolated diastolic hypertension and SDH, whereas higher SBP was associated with all 3 hypertension subtypes. On follow‐up (median, 5.5 years), isolated diastolic hypertension often reverted to nonhypertensive BP (in 42% of participants) and ISH progressed to SDH (in 26% of participants), whereas SDH frequently transitioned to ISH (in 20% of participants). During follow‐up (median, 14.6 years), 889 participants developed cardiovascular disease. Compared with the nonhypertensive group (referent), ISH (adjusted hazard ratio [HR], 1.57; 95% CI, 1.30–1.90) and SDH (HR, 1.66; 95% CI, 1.36–2.01) were associated with increased cardiovascular disease risk, whereas isolated diastolic hypertension was not (HR, 1.03; 95% CI, 0.68–1.57). Conclusions: Hypertension subtypes vary in prevalence with age, are dynamic during short‐term follow‐up, and exhibit distinctive prognoses, underscoring the importance of blood pressure subphenotyping.
- Open Access
- 7 September 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (9) , e0254577
Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study
Background: Circulating levels of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), are positively associated with the prevalence of metabolic syndrome (MetS) in cross-sectional investigations. It is unclear if circulating ADMA and other methylarginines are associated with incident MetS prospectively. Methods: We related circulating ADMA, symmetric dimethylarginine (SDMA), L-arginine (ARG) concentrations (measured with a validated tandem mass spectrometry assay) and the ARG/ADMA ratio to MetS and its components in 2914 (cross-sectional analysis, logistic regression; mean age 58 years, 55% women) and 1656 (prospective analysis, Cox regression; mean age 56 years, 59% women) individuals from the Framingham Offspring Study who attended a routine examination. Results: Adjusting for age, sex, smoking, and eGFR, we observed significant associations of ADMA (direct) and ARG/ADMA (inverse) with odds of MetS (N = 1461 prevalent cases; Odds Ratio [OR] per SD increment 1.13, 95%CI 1.04–1.22; and 0.89, 95%CI 0.82–0.97 for ADMA and ARG/ADMA, respectively). Upon further adjustment for waist circumference, systolic and diastolic blood pressure, glucose, high-density lipoprotein cholesterol, and triglycerides, we observed a positive relation between SDMA and MetS (OR per SD increment 1.15, 95% CI 1.01–1.30) but the other associations were rendered statistically non-significant. We did not observe statistically significant associations between any of the methylarginines and the risk of new-onset MetS (752 incident events) over a median follow-up of 11 years. Conclusion: It is unclear whether dimethylarginines play an important role in the incidence of cardiometabolic risk in the community, notwithstanding cross-sectional associations. Further studies of larger samples are needed to replicate our findings.
- 7 September 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (9) , e0254577
Open AccessAssociations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study
Background: Circulating levels of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), are positively associated with the prevalence of metabolic syndrome (MetS) in cross-sectional investigations. It is unclear if circulating ADMA and other methylarginines are associated with incident MetS prospectively. Methods: We related circulating ADMA, symmetric dimethylarginine (SDMA), L-arginine (ARG) concentrations (measured with a validated tandem mass spectrometry assay) and the ARG/ADMA ratio to MetS and its components in 2914 (cross-sectional analysis, logistic regression; mean age 58 years, 55% women) and 1656 (prospective analysis, Cox regression; mean age 56 years, 59% women) individuals from the Framingham Offspring Study who attended a routine examination. Results: Adjusting for age, sex, smoking, and eGFR, we observed significant associations of ADMA (direct) and ARG/ADMA (inverse) with odds of MetS (N = 1461 prevalent cases; Odds Ratio [OR] per SD increment 1.13, 95%CI 1.04–1.22; and 0.89, 95%CI 0.82–0.97 for ADMA and ARG/ADMA, respectively). Upon further adjustment for waist circumference, systolic and diastolic blood pressure, glucose, high-density lipoprotein cholesterol, and triglycerides, we observed a positive relation between SDMA and MetS (OR per SD increment 1.15, 95% CI 1.01–1.30) but the other associations were rendered statistically non-significant. We did not observe statistically significant associations between any of the methylarginines and the risk of new-onset MetS (752 incident events) over a median follow-up of 11 years. Conclusion: It is unclear whether dimethylarginines play an important role in the incidence of cardiometabolic risk in the community, notwithstanding cross-sectional associations. Further studies of larger samples are needed to replicate our findings.
- Open Access
- 17 August 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (16) , e020301
Association of Mildly Reduced Kidney Function With Cardiovascular Disease: The Framingham Heart Study
Background: Data are limited on the association of mildly reduced estimated glomerular filtration rate (eGFR 60–89 mL/min per 1.73 m 2 ) with cardiovascular disease (CVD) in the community. Methods and Results: We evaluated 3066 Framingham Offspring Study participants (55% women, mean age 58 years), without clinical CVD. Using multivariable regression, we related categories of mildly reduced eGFR (80–89, 70–79, or 60–69 versus ≥90 mL/min per 1.73 m 2 [referent]) to prevalent coronary artery calcium, carotid intima media thickness, and left ventricular hypertrophy, and to circulating concentrations of cardiac stress biomarkers. We related eGFR categories to CVD incidence and to progression to ≥Stage 3 chronic kidney disease (eGFR 2 ) using Cox regression. Individuals with eGFR 60–69 mL/min per 1.73 m 2 (n=320) had higher coronary artery calcium score (odds ratio 1.69; 95% CI 1.02–2.80) compared with the referent group. Individuals with eGFR 60–69 and 70–79 mL/min per 1.73 m 2 had higher blood growth differentiating factor‐15 concentrations (β=0.131 and 0.058 per unit‐increase in log‐biomarker, respectively). Participants with eGFR 60–69 and 80–89 mL/min per 1.73 m 2 had higher blood B‐type natriuretic peptide concentrations (β=0.119 and 0.116, respectively). On follow‐up (median 16 years; 691 incident CVD and 252 chronic kidney disease events), individuals with eGFR 60–69 and 70–79 mL/min per 1.73 m 2 experienced higher CVD incidence (hazard ratio [HR], 1.40; 95% CI, 1.02–1.93 and 1.45, 95% CI, 1.05–2.00, respectively, versus referent). Participants with eGFR 60–69 mL/min per 1.73 m 2 experienced higher chronic kidney disease incidence (HR, 2.94; 95% CI, 1.80–4.78 versus referent). Conclusions: Individuals with mildly reduced eGFR 60–69 mL/min per 1.73 m 2 have a higher burden of subclinical atherosclerosis cross‐sectionally, and a greater risk of CVD and chronic kidney disease progression prospectively. Additional studies are warranted to confirm our findings.
- 17 August 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (16) , e020301
Open AccessAssociation of Mildly Reduced Kidney Function With Cardiovascular Disease: The Framingham Heart Study
Background: Data are limited on the association of mildly reduced estimated glomerular filtration rate (eGFR 60–89 mL/min per 1.73 m 2 ) with cardiovascular disease (CVD) in the community. Methods and Results: We evaluated 3066 Framingham Offspring Study participants (55% women, mean age 58 years), without clinical CVD. Using multivariable regression, we related categories of mildly reduced eGFR (80–89, 70–79, or 60–69 versus ≥90 mL/min per 1.73 m 2 [referent]) to prevalent coronary artery calcium, carotid intima media thickness, and left ventricular hypertrophy, and to circulating concentrations of cardiac stress biomarkers. We related eGFR categories to CVD incidence and to progression to ≥Stage 3 chronic kidney disease (eGFR 2 ) using Cox regression. Individuals with eGFR 60–69 mL/min per 1.73 m 2 (n=320) had higher coronary artery calcium score (odds ratio 1.69; 95% CI 1.02–2.80) compared with the referent group. Individuals with eGFR 60–69 and 70–79 mL/min per 1.73 m 2 had higher blood growth differentiating factor‐15 concentrations (β=0.131 and 0.058 per unit‐increase in log‐biomarker, respectively). Participants with eGFR 60–69 and 80–89 mL/min per 1.73 m 2 had higher blood B‐type natriuretic peptide concentrations (β=0.119 and 0.116, respectively). On follow‐up (median 16 years; 691 incident CVD and 252 chronic kidney disease events), individuals with eGFR 60–69 and 70–79 mL/min per 1.73 m 2 experienced higher CVD incidence (hazard ratio [HR], 1.40; 95% CI, 1.02–1.93 and 1.45, 95% CI, 1.05–2.00, respectively, versus referent). Participants with eGFR 60–69 mL/min per 1.73 m 2 experienced higher chronic kidney disease incidence (HR, 2.94; 95% CI, 1.80–4.78 versus referent). Conclusions: Individuals with mildly reduced eGFR 60–69 mL/min per 1.73 m 2 have a higher burden of subclinical atherosclerosis cross‐sectionally, and a greater risk of CVD and chronic kidney disease progression prospectively. Additional studies are warranted to confirm our findings.
- 1 April 2021
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 14 (2) , 246-248
Shared Genetic and Environmental Architecture of Cardiac Phenotypes Assessed via Echocardiography
- 1 April 2021
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 14 (2) , 246-248
Shared Genetic and Environmental Architecture of Cardiac Phenotypes Assessed via Echocardiography
- Open Access
- 16 February 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0246355
Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study
Background: Lung function abnormalities are ubiquitous in heart failure (HF). It is unclear, however, if abnormal lung diffusion capacity is associated with cardiac remodeling and antedates HF. We hypothesized that lower lung diffusion capacity for carbon monoxide (DLCO) is associated with worse left ventricular (LV) systolic and diastolic function cross-sectionally, and with higher risk of HF prospectively. Methods: We evaluated 2423 Framingham Study participants (mean age 66 years, 55% women) free of HF who underwent routine echocardiography and pulmonary function tests. We used multivariable regression models to relate DLCO, forced vital capacity (FVC), and forced expiratory volume in 1 second (FEV1) to left ventricular ejection fraction (LVEF), left atrial (LA) emptying fraction (LAEF), E/e’, E/A, LV mass, and LA diameter (LAD). Multivariable-adjusted Cox proportional hazards regression was used to relate DLCO, FEV1, and FVC to incident HF. Results: In multivariable-adjusted cross-sectional analyses, DLCO, FEV1, and FVC (dependent variables) were associated positively with LVEF (βDLCO = 0.208, βFEV1 = 0.021, and βFVC = 0.025 per 5% increment in LVEF; pDLCO = 0.707, βFEV1 = 0.058 and βFVC = 0.058 per 5% increment in LAEF; pDLCO = -0.289, βFVC = -0.047 per SD increment in E/A; p<0.001 for all). Additionally, DLCO, FEV1 and FVC were inversely related to HF risk (108 events, median follow-up 9.7 years; multivariable-adjusted hazard ratios per SD increment 0.90, 95% CI 0.86–0.95; 0.42, 95% CI 0.28–0.65, and 0.51, 95% CI 0.36–0.73, respectively). These results remained robust in analyses restricted to non-smokers. Conclusions: Our large community-based observations are consistent with the concept that lower lung diffusion capacity and expiratory flow rates are associated with cardiac remodeling and may antedate HF. Additional studies are needed to confirm our findings and to evaluate the prognostic utility of pulmonary function testing for predicting HF.
- 16 February 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0246355
Open AccessAssociation of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study
Background: Lung function abnormalities are ubiquitous in heart failure (HF). It is unclear, however, if abnormal lung diffusion capacity is associated with cardiac remodeling and antedates HF. We hypothesized that lower lung diffusion capacity for carbon monoxide (DLCO) is associated with worse left ventricular (LV) systolic and diastolic function cross-sectionally, and with higher risk of HF prospectively. Methods: We evaluated 2423 Framingham Study participants (mean age 66 years, 55% women) free of HF who underwent routine echocardiography and pulmonary function tests. We used multivariable regression models to relate DLCO, forced vital capacity (FVC), and forced expiratory volume in 1 second (FEV1) to left ventricular ejection fraction (LVEF), left atrial (LA) emptying fraction (LAEF), E/e’, E/A, LV mass, and LA diameter (LAD). Multivariable-adjusted Cox proportional hazards regression was used to relate DLCO, FEV1, and FVC to incident HF. Results: In multivariable-adjusted cross-sectional analyses, DLCO, FEV1, and FVC (dependent variables) were associated positively with LVEF (βDLCO = 0.208, βFEV1 = 0.021, and βFVC = 0.025 per 5% increment in LVEF; pDLCO = 0.707, βFEV1 = 0.058 and βFVC = 0.058 per 5% increment in LAEF; pDLCO = -0.289, βFVC = -0.047 per SD increment in E/A; p<0.001 for all). Additionally, DLCO, FEV1 and FVC were inversely related to HF risk (108 events, median follow-up 9.7 years; multivariable-adjusted hazard ratios per SD increment 0.90, 95% CI 0.86–0.95; 0.42, 95% CI 0.28–0.65, and 0.51, 95% CI 0.36–0.73, respectively). These results remained robust in analyses restricted to non-smokers. Conclusions: Our large community-based observations are consistent with the concept that lower lung diffusion capacity and expiratory flow rates are associated with cardiac remodeling and may antedate HF. Additional studies are needed to confirm our findings and to evaluate the prognostic utility of pulmonary function testing for predicting HF.
- 26 March 2020
- Published by SAGE Publications in The International Journal of Psychiatry in Medicine
- Vol. 56 (2) , 97-115
Posttraumatic stress disorder and psycho-social impairment following snakebite in Northeastern Nigeria
Background: Snakebite is a major public health problem among impoverished rural populations causing considerable morbidity and mortality in West Africa. Despite the huge burden of snakebite in this region, psycho-social impairment following snakebite has not been evaluated. In this study, we assessed for features of posttraumatic stress disorder and psycho-social impairment among rural snakebite victims in Northeastern Nigeria. Methods: Individuals with previous snakebite managed in our facility, defined as exposed to snakebite, and their matched relatives not exposed to snakebite were invited to participate in the study following community mobilization. A retrospective cohort study was conducted evaluating the presence of psycho-social functioning, posttraumatic stress disorder, quality of life, social disability, cognitive impairment, and psychological morbidity using standard tools administered by the investigators, trained nurses, and community health workers. Results: The prevalence of features of posttraumatic stress disorder among those exposed to snakebite compared to those not exposed to snakebite was 43% and 28%, respectively (risk ratio = 1.53; 95% confidence interval: 1.04–2.24; p = 0.024). Subjects exposed to snakebite had significantly poorer quality of life score in the psychological and social domains (p < 0.05). Other psycho-social complications associated with snakebite were impaired family/school functioning and psychological morbidity. No difference in cognitive functioning was observed between the two groups. Conclusions: Snakebite is complicated by features of posttraumatic stress disorder, poor quality of life, and psycho-social impairments in northeastern Nigeria. Detection, monitoring, and appropriate management interventions should be provided and made more accessible to snakebite victims to ameliorate mental and psychological impairment.
- 26 March 2020
- Published by SAGE Publications in The International Journal of Psychiatry in Medicine
- Vol. 56 (2) , 97-115
Posttraumatic stress disorder and psycho-social impairment following snakebite in Northeastern Nigeria
Background: Snakebite is a major public health problem among impoverished rural populations causing considerable morbidity and mortality in West Africa. Despite the huge burden of snakebite in this region, psycho-social impairment following snakebite has not been evaluated. In this study, we assessed for features of posttraumatic stress disorder and psycho-social impairment among rural snakebite victims in Northeastern Nigeria. Methods: Individuals with previous snakebite managed in our facility, defined as exposed to snakebite, and their matched relatives not exposed to snakebite were invited to participate in the study following community mobilization. A retrospective cohort study was conducted evaluating the presence of psycho-social functioning, posttraumatic stress disorder, quality of life, social disability, cognitive impairment, and psychological morbidity using standard tools administered by the investigators, trained nurses, and community health workers. Results: The prevalence of features of posttraumatic stress disorder among those exposed to snakebite compared to those not exposed to snakebite was 43% and 28%, respectively (risk ratio = 1.53; 95% confidence interval: 1.04–2.24; p = 0.024). Subjects exposed to snakebite had significantly poorer quality of life score in the psychological and social domains (p < 0.05). Other psycho-social complications associated with snakebite were impaired family/school functioning and psychological morbidity. No difference in cognitive functioning was observed between the two groups. Conclusions: Snakebite is complicated by features of posttraumatic stress disorder, poor quality of life, and psycho-social impairments in northeastern Nigeria. Detection, monitoring, and appropriate management interventions should be provided and made more accessible to snakebite victims to ameliorate mental and psychological impairment.
- Open Access
- 10 January 2017
- Published by Sciencedomain International in British Journal of Medicine and Medical Research
- Vol. 19 (10) , 1-15
Profile of Neurocognitive Impairment in Individuals Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus: Meta-analysis and Meta-regression
HIV and HCV are neurotrophic viruses with great potential to cause neurocognitive impairments (NCI). Yet, results of neuro studies among Coinfected individuals are still inconclusive. This study pooled estimates to define the neurocognitive profile and neuroepidemiology of Coinfection in relation to monoinfection. Data from the qualified studies was grouped in to seven neurologic domains to yield weighted average effect sizes (WAES) which were pooled together in meta-analyses. Further assessments were meta-regression analysis, sensitivity analysis and computation of heterogeneity diagnostic indices. From eleven studies the pooled estimates showed that only the Coinfected group had a medium effect size (ES) in speed of information processing (SIP). Other neurologic domains exhibiting a medium ES across all the study groups were executive function (EF) and attention/working memory. These neurocognitive deficits epidemiologically translates in to NCI prevalence of 47% among Coinfected group who were also twice more likely to be neurocognitively impaired compared to HIV monoinfection group. Despite substantial heterogeneity, Kernel density plot of WAES approximates to normal distribution making publication bias unlikely. Coinfection is associated with deficit in SIP, EF and attention/working memory with substantial risk of global NCI underscoring the need for medical and psychosocial interventions to improve the lives of affected individuals.
- 10 January 2017
- Published by Sciencedomain International in British Journal of Medicine and Medical Research
- Vol. 19 (10) , 1-15
Open AccessProfile of Neurocognitive Impairment in Individuals Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus: Meta-analysis and Meta-regression
HIV and HCV are neurotrophic viruses with great potential to cause neurocognitive impairments (NCI). Yet, results of neuro studies among Coinfected individuals are still inconclusive. This study pooled estimates to define the neurocognitive profile and neuroepidemiology of Coinfection in relation to monoinfection. Data from the qualified studies was grouped in to seven neurologic domains to yield weighted average effect sizes (WAES) which were pooled together in meta-analyses. Further assessments were meta-regression analysis, sensitivity analysis and computation of heterogeneity diagnostic indices. From eleven studies the pooled estimates showed that only the Coinfected group had a medium effect size (ES) in speed of information processing (SIP). Other neurologic domains exhibiting a medium ES across all the study groups were executive function (EF) and attention/working memory. These neurocognitive deficits epidemiologically translates in to NCI prevalence of 47% among Coinfected group who were also twice more likely to be neurocognitively impaired compared to HIV monoinfection group. Despite substantial heterogeneity, Kernel density plot of WAES approximates to normal distribution making publication bias unlikely. Coinfection is associated with deficit in SIP, EF and attention/working memory with substantial risk of global NCI underscoring the need for medical and psychosocial interventions to improve the lives of affected individuals.
- Open Access
- 9 May 2016
- Published by Edorium Journals Pvt. Ltd. in International Journal of Blood Transfusion and Immunohematology
- Vol. 6 (1) , 1-8
Serosurvey of human T cell lymphotropic virus I/II among blood donors in Gombe (Nigeria)
Aim: This study was carried out to determine the prevalence of human T cell lymphotropic virus I/II (HTLV I/II) among blood donors at the Federal Teaching Hospital Gombe (FTHG), North-eastern, Nigeria. Methods: A total of 355 blood donors were recruited at the hematology department of FTHG for a hospital based cross-sectional study and were screened/confirmed for HTLV I/II by ELISA and western blot methods. Results: Seroprevalence of HTLV I/II among the 355 participants with mean age of 30.77 years (±8.27) was 6.5% on screening with ELISA but confirmed to be 0% by western blot. Majority were males, 352 (99.2%) and mostly (45.9%) between 21–30 years of age. Donors for family replacements predominated (85.1%) with more than half (58.6%) being first time blood donors. Conclusion: This study reveals the absence of HTLV I/II among blood donors in Gombe North-eastern Nigeria. It also highlights the possibility of false positivity in some of the reported prevalence of HTLV I and II from some parts of Nigeria that were based on screening tests only. The importance of confirmatory testing in all research works on HTLV (including HTLV 3 and HTLV 4) is further strengthened with this study. There is however the need for a larger study and the use of molecular diagnostics to reconfirm this assertion.
- 9 May 2016
- Published by Edorium Journals Pvt. Ltd. in International Journal of Blood Transfusion and Immunohematology
- Vol. 6 (1) , 1-8
Open AccessSerosurvey of human T cell lymphotropic virus I/II among blood donors in Gombe (Nigeria)
Aim: This study was carried out to determine the prevalence of human T cell lymphotropic virus I/II (HTLV I/II) among blood donors at the Federal Teaching Hospital Gombe (FTHG), North-eastern, Nigeria. Methods: A total of 355 blood donors were recruited at the hematology department of FTHG for a hospital based cross-sectional study and were screened/confirmed for HTLV I/II by ELISA and western blot methods. Results: Seroprevalence of HTLV I/II among the 355 participants with mean age of 30.77 years (±8.27) was 6.5% on screening with ELISA but confirmed to be 0% by western blot. Majority were males, 352 (99.2%) and mostly (45.9%) between 21–30 years of age. Donors for family replacements predominated (85.1%) with more than half (58.6%) being first time blood donors. Conclusion: This study reveals the absence of HTLV I/II among blood donors in Gombe North-eastern Nigeria. It also highlights the possibility of false positivity in some of the reported prevalence of HTLV I and II from some parts of Nigeria that were based on screening tests only. The importance of confirmatory testing in all research works on HTLV (including HTLV 3 and HTLV 4) is further strengthened with this study. There is however the need for a larger study and the use of molecular diagnostics to reconfirm this assertion.
- 13 January 2015
- Published by Wiley in The Laryngoscope
- Vol. 125 (8) , 1996-2000
Electrophysiologic identification and monitoring of the external branch of superior laryngeal nerve during thyroidectomy
Objective: The aim of the study is to examine the correlation between weight, gender, and race with external branch of superior laryngeal nerve (EBSLN) visualization. Furthermore, we compared normative EBSLN neural‐monitoring values to those of the recurrent laryngeal nerve (RLN).Study Design: Retrospective study.Setting: North American tertiary academic hospital.Subjects and Methods: A retrospective, institutional review board‐approved review was carried out on patients undergoing thyroid surgery by a single surgeon over 3.5 years. Preoperative and postoperative laryngoscopy was done on all patients in accordance with recently published American Academy of Otolaryngology voice optimization at thyroidectomy guidelines, and patients' clinical and operative relevant data were collected.Results: A total of 447 nerves were at risk in 371 thyroidectomy patients. Of these nerves at risk, 237 (53.02%) were visualized and stimulated. The average amplitude and latency for the EBSLN were significantly lower when compared to the amplitude and the latency of RLN stimulation (P < 0.0001, P < 0.0001, respectively). There was no gender or racial disparity. Out of our study population, the EBSLN was identified in 64.56% in nonobese patients, whereas it was only 40.00% in obese patients (P < 0.001). Additionally, of the 56 patients in whom the EBSLN was visualized on one side and who further underwent bilateral neck exploration, 41 (73%) had visualization of the nerve on the contralateral side as well.Conclusion: EBSLN is less likely to be visualized in obese patients; however, there was no gender or racial disparity. Stimulation of EBSLN was felt to be a useful adjunct during superior pole dissection to assure the nerve integrity.Level of Evidence: 4. Laryngoscope, 125:1996–2000, 2015
- 13 January 2015
- Published by Wiley in The Laryngoscope
- Vol. 125 (8) , 1996-2000
Electrophysiologic identification and monitoring of the external branch of superior laryngeal nerve during thyroidectomy
Objective: The aim of the study is to examine the correlation between weight, gender, and race with external branch of superior laryngeal nerve (EBSLN) visualization. Furthermore, we compared normative EBSLN neural‐monitoring values to those of the recurrent laryngeal nerve (RLN).Study Design: Retrospective study.Setting: North American tertiary academic hospital.Subjects and Methods: A retrospective, institutional review board‐approved review was carried out on patients undergoing thyroid surgery by a single surgeon over 3.5 years. Preoperative and postoperative laryngoscopy was done on all patients in accordance with recently published American Academy of Otolaryngology voice optimization at thyroidectomy guidelines, and patients' clinical and operative relevant data were collected.Results: A total of 447 nerves were at risk in 371 thyroidectomy patients. Of these nerves at risk, 237 (53.02%) were visualized and stimulated. The average amplitude and latency for the EBSLN were significantly lower when compared to the amplitude and the latency of RLN stimulation (P < 0.0001, P < 0.0001, respectively). There was no gender or racial disparity. Out of our study population, the EBSLN was identified in 64.56% in nonobese patients, whereas it was only 40.00% in obese patients (P < 0.001). Additionally, of the 56 patients in whom the EBSLN was visualized on one side and who further underwent bilateral neck exploration, 41 (73%) had visualization of the nerve on the contralateral side as well.Conclusion: EBSLN is less likely to be visualized in obese patients; however, there was no gender or racial disparity. Stimulation of EBSLN was felt to be a useful adjunct during superior pole dissection to assure the nerve integrity.Level of Evidence: 4. Laryngoscope, 125:1996–2000, 2015